Replies to post #4500 on Revance Therapeutics Inc (RVNC)

[10nisman]

Investing can be gut-wrenching, especially at times like these. The people who have been critical of management have been proven right.

That is why it's important to understand what you're investing in and assessing the value of what you own --- and ignore the current share price until you assess the underlying value. No management team is perfect and there's definitely been a good number of mishaps here, however, if it wasn't clear based on the pricing strategy adjustment earlier this month --- it should be obviously after today's call --- Management is listening to the marketplace and proactively managing the business. Everyone should be critical of all Management teams, however, humans make mistakes and we shouldn't be focused on the fact that errors take place (that's expected) but we should be focused on the severity of the error, the ability to quickly identify the error, and the willingness to quickly right the wrong (that's what good management teams do). I think it's pretty clear Management identified an issue in real-time and acted very quickly to resolve it.

I am not as brave or confident as you 10nisman but I did buy a bit more at $12.85. Let the cards fall where they may but I have a long time line.

I dream of buying opportunity days like today. We know the value of RVNC is primarily Daxxify, but did the underlying long-term value of Daxxify decline today? IMHO, worst case Foley puts RVNC in play in 12-18 months and the business sells for a premium to today's share price. So, limited downside (although nobody knows where the market may take the share price) compared to the potential upside.